METHODS	In this multicenter , open-label , randomized , 2-sequence , 2-period crossover study , patients with primary hypercholesterolemia randomly received ezetimibe/simvastatin 10 mg/20 mg once daily , either in the morning ( within 1 hour of breakfast ) or in the evening ( within 1 hour of dinner ) for 6 weeks .\